15 Best Undervalued Stocks to Buy Now
Investing in the stock market could be difficult. We can classify investors based on their portfolios.
Posts Tagged ‘bluebird bio Inc (BLUE)’
Hedge Fund and Insider Trading News: Paul Singer, Jeffrey Talpins, PointState Capital, Brevan Howard Asset Management, Sutter Rock Capital Corp (SSSS), Nordson Corporation (NDSN), and More
PointState Capital, the macro hedge fund started by former traders for billionaire Stan Druckenmiller, is blocking investors who ask to pull their money out from getting their...
Hedge Fund and Insider Trading News: Brevan Howard Asset Management, EJF Capital, David Einhorn, CoreSite Realty Corp (COR), Caesars Entertainment Co. (CZR), Restoration Robotics Inc (HAIR), and More
Brevan Howard Asset Management, the hedge fund manager run by billionaire Alan Howard, has shrunk the size of its London headquarters, cutting back on space previously used as...
Five Stocks To Buy According To Top Biotech-Focused Funds
Biotechnology is a very interesting industry to invest in, but also very complex.
bluebird bio Inc (BLUE), Iqvia Holdings Inc (IQV): Four Biotech Stocks to Buy Now
Healthcare sector has proven itself to be one of the most resilient sectors of the US economy.
Here’s What’s So Important About The bluebird bio Inc (BLUE) Data
bluebird bio Inc (NASDAQ:BLUE) is up sharply pre market on Thursday, as the company put out fresh interim data from a phase I study of its multiple myeloma (MM) asset, bb2121.
Cupps Capital Slashes Portfolio in Q3, But Couldn’t Stop Buying These 5 Stocks
Drew Cupps' Chicago-based asset management firm, Cupps Capital Management, has been in the news of late after it announced that its five-member investment team will be joining...
Spark Therapeutics Inc (ONCE) and Other Profitable Healthcare Picks of Casdin Capital
At Insider Monkey, we track some 750 hedge funds and other institutional investors.
What is Going On With These 4 Plunging Stocks?
Shares of Freeport-McMoRan Inc (NYSE:FCX), Qiagen NV (NASDAQ:QGEN), McKesson Corporation (NYSE:MCK), and bluebird bio Inc (NASDAQ:BLUE) are deep in the red on Monday as investors...
Why Are Investors Heading For The Exits In These Five Stocks Today?
In yet another volatile trading session, the S&P 500 is off by more than 0.8% and the NASDAQ is down by 0.84% as investors weigh the negative implications of a Federal Reserve...
bluebird bio Inc (BLUE), Nektar Therapeutics (NKTR) Among Billionaire Stan Druckenmiller’s Top Small-Cap Picks
Stan Druckenmiller’s Duquesne Family Office LLC, previously Duquesne Capital, has filed its 13F for the reporting period of March 31.
Biogen Idec Inc (BIIB), Celgene Corporation (CELG), bluebird bio Inc (BLUE): Stanley Druckenmiller Bets on Biotech and Wins
In the last couple of years, biotechnology industry has been a hot topic and investors have been watching closely as the industry gained on average 40% in the last three years...
Druckenmiller, Buffett At Odds On International Business Machines Corp. (IBM): What Do Hedge Funds Think? Plus Druckenmiller’s Top New Picks
Duquesne Capital’s Stanley Druckenmiller respects Warren Buffett’s opinion on International Business Machines Corp. (NYSE:IBM); he just doesn’t agree with it.
Gilead Sciences (GILD), AstraZeneca (AZN), Bellicum Pharmaceuticals (BLCM): Redmile Group’s Top New Picks
Jeremy Green’s Redmile Group entered several new positions last quarter, as revealed by the 13F Form it filed with the U.S. Securities and Exchange Commission in February.
